Melatonin as a modulator of cancer endocrine therapy

Frontiers of Hormone Research

Volumn 23, Issue , 1997, Pages 132-136

  Lissoni, Paolo ^a   Paolorossi, Franco ^a   Meregalli, Sofia ^a   Ardizzoia, Antonio ^a   Barni, Sandro ^a   Tancini, Gariele ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004461485     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060990     Document Type: Review

References (6)

1. Regelson W, Pierpaoli W: Melatonin: A rediscovered antitumor hormone? Cancer Invest 1987;5:379-385.
2. Maestroni GJM: The immunoneuroendocrine role of melatonin. J Pineal Res 1993;14:1-10.
3. Lissoni P, Tisi E, Brivio F, Ardizzoia A, Crispino S, Barni S, Tancini G, Conti A, Maestroni GJM: Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatonin. J Biol Regul Homeost Agents 1991;5:154-156.
4. Gonzales R, Sachez A, Ferguson JA, Balmer C, Daniel C, Cohn A, Robinson WA: Melatonin therapy of advanced human malignant melanoma. Melanoma Res 1991;1:237-243.
5. Lissoni P, Barni S, Tancini G, Ardizzoia A, Ricci G, Aldeghi R, Brivio F, Tisi E, Rovelli F, Rescaldani R, Quadro G, Maestroni G: A randomised study with subcutaneous low-dose interleukin-2 alone vs interleukin-2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma. Br J Cancer 1994;69:196-199.
6. Lissoni P, Barni S, Meregalli S, Fossati V, Cazzaniga M, Esposti D, Tancini G: Modulation of cancer endocrine therapy by melatonin: A phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. Br J Cancer 1995;71:854-856.